Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. blood flow
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • This Year
  • Older

Blood Flow Articles & Analysis

156 news found

Cells: Hemostemix ACP-01 and NCP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants

Cells: Hemostemix ACP-01 and NCP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants

Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is excited to highlight a groundbreaking research article published in Cells on June?29,?2025, by Dr. Fraser C. Henderson Sr. and Ms. Kelly?Tuchman, exploring how a combination of the patient’s own ACP-01 and NCP-01 (autologous blood-derived cell precursors) may support the long-term ...

ByHemostemix Inc.


AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F1885 System

AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F1885 System

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced European CE Mark approval of the AlphaVac F1885 System for the non-surgical removal of thrombi or emboli from the pulmonary ...

ByAngioDynamics, Inc.


Revolutionising Cardiovascular Health: Monitoring the Surface Metallurgy of Stents

Revolutionising Cardiovascular Health: Monitoring the Surface Metallurgy of Stents

Surgical stents, wireframe scaffolds typically laser-cut from stainless steel, play a vital role in holding narrowed arteries open, ensuring blood flows unimpeded through the body’s vital pathways. The insertion of these stents via a catheter, followed by expansion with a small balloon, is a life-saving procedure for countless patients worldwide. ...

ByHiden Analytical Ltd.


AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the completion of patient enrollment in the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV). ...

ByAngioDynamics, Inc.


More than muscles: Sports nutrition evolves

More than muscles: Sports nutrition evolves

The ingredient has been shown to extend endurance performance as well as optimize heart rate, blood flow and oxygen use for endurance training. The dark purple water-soluble powder works in applications such as pre-workout formulas, electrolyte drinks and sport powder ...

ByNuritas Ltd.


Bayer receives U.S. FDA Fast Track Designation for asundexian atrial fibrillation program

Bayer receives U.S. FDA Fast Track Designation for asundexian atrial fibrillation program

About FXIa inhibitors and Asundexian Factor XI is a protein in the blood which is converted into its active enzyme form (Factor XIa) as part of the blood coagulation cascade. ...

ByBayer AG


Kardiolytics’ VCAST Technology Offers Non-Invasive and Safe Solution for Functional Evaluation of Coronary Disease, According to Recent Study in Cardiovascular Engineering and Technology

Kardiolytics’ VCAST Technology Offers Non-Invasive and Safe Solution for Functional Evaluation of Coronary Disease, According to Recent Study in Cardiovascular Engineering and Technology

Using a comparative method to simulate flow energy losses in real and reconstructed models of the coronary arteries, the study confirms the potential of medical image-based Computational Fluid Dynamic methods in the clinical setting for flow studies of the cardiovascular system. The publication presents results obtained from flow simulations in ...

ByMedicalgorithmics S.A.


BIOtechNOW featured IVS’s participating BIO Innovation Zone

BIOtechNOW featured IVS’s participating BIO Innovation Zone

The leading use of nanoRBC is in correcting insufficient blood flow and oxygen supply in critical care patients and those in need of blood transfusions. ...

ByInvivoSciences, Inc. (IVS)


HTG Used for First Time in Congenital Heart Defect Surgery

HTG Used for First Time in Congenital Heart Defect Surgery

Infants with CAVC may have trouble feeding and growing at a normal rate and may breathe faster and harder than normal, which causes permanent damage to the lung blood vessels over time. An AV canal can be fixed by surgery where valves and heart chamber walls are reconstructed to ensure proper blood flow. ...

ByEchoPixel, Inc.


An Easy, Predictable, and Simpler Way to Embolize Tumors

An Easy, Predictable, and Simpler Way to Embolize Tumors

The laundry list the founding team put together was detailed: a water-based product that could penetrate the deepest part of the tumor vasculature, fill the vessels, and quickly and completely stop blood flow regardless of the patient’s coagulation status; avoid CT or MR imaging artifact; absorb over time; and, if it were to flow in an ...

ByInstylla, Inc.


XyloCor Therapeutics Commences Phase 2 Component of Phase 1/2 EXACT Clinical Study of XC001 Gene Therapy for Refractory Angina

XyloCor Therapeutics Commences Phase 2 Component of Phase 1/2 EXACT Clinical Study of XC001 Gene Therapy for Refractory Angina

“With a unique mechanism of action that restores blood flow to the heart via the creation of new blood vessels, XC001 represents a novel therapeutic approach for patients who have exhausted other medical and surgical options. ...

ByXyloCor Therapeutics


Creative Enzymes Launches Raw Materials for Manufacturing Diagnostic Kits

Creative Enzymes Launches Raw Materials for Manufacturing Diagnostic Kits

Creatinine Assay Kit Altered creatinine levels can be an indicator of kidney dysfunction or other medical conditions that result in lower renal blood flow such as diabetes or cardiovascular disease. Creative Enzymes provides high-quality creatinase (EC 3.5.3.3), creatininase (EC 3.5.2.10), and sarcosine oxidase (EC 1.5.3.1), which are raw materials used in the ...

ByCreative Enzymes


Prof. Krestin Joins Fluidda’S Board of Directors

Prof. Krestin Joins Fluidda’S Board of Directors

For example, it is possible to quantify diseases of the airways and at the same time disturbances in the blood flow. As such, FRI provides radiologists with the data needed to make more informed decisions. ...

ByFluidda


VQB Wins $1 Million to Commercialize System for Early Detection of DPN

VQB Wins $1 Million to Commercialize System for Early Detection of DPN

VisionQuest Biomedical founder and CEO Peter Soliz (PhD) has just been awarded a $1 million Commercialization Readiness Pilot Program (CRP) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (part of the US National Institutes of Health) for his work on early detection of DPN. With the support of this grant, Dr. Soliz will develop a commercial prototype and seek FDA ...

ByVisionQuest Biomedical Inc.


ABK Biomedical announces FDA 510(k) clearance of Easi-Vue™ embolic microspheres for the embolization of arteriovenous malformations and hypervascular tumors

ABK Biomedical announces FDA 510(k) clearance of Easi-Vue™ embolic microspheres for the embolization of arteriovenous malformations and hypervascular tumors

Hypervascular tumors occur in both benign and malignant states and are characterized by blood supply from an abnormally large number of blood vessels. Microspheres embolization reduces or eliminates the blood flow to these tumors and is an effective interventional radiology therapy for treating this disease state. ...

ByABK Biomedical Inc.


Gesynta Pharma presents results from an exploratory clinical study of its drug candidate GS-248

Gesynta Pharma presents results from an exploratory clinical study of its drug candidate GS-248

The objectives of the recently concluded explorative Phase II study included investigating the safety profile of GS-248, its ability to inhibit mPGES-1, as well as its effect on Raynaud's phenomenon and peripheral blood flow in systemic sclerosis patients. In total, 69 patients were included and received either 120 mg of GS-248, or placebo, once daily for four ...

ByGesynta Pharma AB


Medical Microinstruments Introduces Even Smaller Robotic Instruments to Address Complex Supermicrosurgery

Medical Microinstruments Introduces Even Smaller Robotic Instruments to Address Complex Supermicrosurgery

Simon Enzinger, MD, DDS, surgeon at the Department of Oral and Maxillofacial Surgery at the University Hospital Salzburg, used the new instruments on a procedure called a partial glossectomy, where he raised a lateral arm free flap to replace a large section of a patient's tongue which required removal due to cancer. To return blood flow to the transferred ...

ByMedical Microinstruments (MMI) S.P.A.


enVVeno Medical Appoints Kevin Belteau as Vice President of Clinical Operations

enVVeno Medical Appoints Kevin Belteau as Vice President of Clinical Operations

The VenoValve is intended to restore proper directional blood flow for patients with CVI of the deep veins of the leg. CVI occurs when the natural valves inside of the veins fail, causing blood to flow in the wrong direction (reflux), and creating increased pressure inside of the veins of the leg (venous hypertension). ...

ByenVVeno Medical


enVVeno Medical Reports Second Quarter 2022 Financial Results and Provides Corporate Update

enVVeno Medical Reports Second Quarter 2022 Financial Results and Provides Corporate Update

CVI occurs when the natural valves inside of the veins fail, causing blood to flow in the wrong direction (reflux), and creating increased pressure inside of the veins of the leg (venous hypertension). ...

ByenVVeno Medical


Rapid Medical Gains FDA Clearance for the Smallest & Only Adjustable Thrombectomy Device

Rapid Medical Gains FDA Clearance for the Smallest & Only Adjustable Thrombectomy Device

TIGERTRIEVER 13 is the smallest revascularization device in the world to date and is designed to remove thrombus from delicate brain blood vessels during an ischemic stroke. It is the only device that adjusts to the vasculature and clot, a more atraumatic approach than existing devices. ...

ByRapid Medical

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT